Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was $5.77 for the day, up 2.67% from the previous closing price of $5.62. In other words, the price has increased by $2.67 from its previous closing price. On the day, 1.24 million shares were traded. PHAT stock price reached its highest trading level at $6.21 during the session, while it also had its lowest trading level at $5.75.
Ratios:
Our analysis of PHAT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.68 and its Current Ratio is at 5.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on February 14, 2025, initiated with a Overweight rating and assigned the stock a target price of $23.
On May 03, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $24.
Needham reiterated its Buy rating for the stock on January 05, 2024, while the target price for the stock was revised from $23 to $26.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 21 ’25 when Henderson Molly sold 6,583 shares for $6.59 per share. The transaction valued at 43,371 led to the insider holds 93,546 shares of the business.
Nabulsi Azmi sold 7,886 shares of PHAT for $51,957 on Jan 21 ’25. The Chief Operating Officer now owns 233,390 shares after completing the transaction at $6.59 per share. On Jan 21 ’25, another insider, Curran Terrie, who serves as the President and Chief Executive of the company, sold 19,109 shares for $6.59 each. As a result, the insider received 125,884 and left with 360,465 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 394537600 and an Enterprise Value of 578851392. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.02. Its current Enterprise Value per Revenue stands at 22.035 whereas that against EBITDA is -2.016.
Stock Price History:
The Beta on a monthly basis for PHAT is 0.63, which has changed by -0.43264502 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $5.21. The 50-Day Moving Average of the stock is -19.89%, while the 200-Day Moving Average is calculated to be -50.26%.
Shares Statistics:
PHAT traded an average of 1.05M shares per day over the past three months and 1031070 shares per day over the past ten days. A total of 68.32M shares are outstanding, with a floating share count of 34.89M. Insiders hold about 48.98% of the company’s shares, while institutions hold 61.78% stake in the company. Shares short for PHAT as of 1738281600 were 14630807 with a Short Ratio of 13.94, compared to 1735603200 on 14954493. Therefore, it implies a Short% of Shares Outstanding of 14630807 and a Short% of Float of 30.200001999999998.
